BR9602024A - Método para a inibição da fotodecomposição de um composto comprimido e cápsula compreendendo um ingrediente farmaceuticamente ativo - Google Patents
Método para a inibição da fotodecomposição de um composto comprimido e cápsula compreendendo um ingrediente farmaceuticamente ativoInfo
- Publication number
- BR9602024A BR9602024A BR9602024A BR9602024A BR9602024A BR 9602024 A BR9602024 A BR 9602024A BR 9602024 A BR9602024 A BR 9602024A BR 9602024 A BR9602024 A BR 9602024A BR 9602024 A BR9602024 A BR 9602024A
- Authority
- BR
- Brazil
- Prior art keywords
- capsule
- inhibiting
- photo
- decomposition
- active ingredient
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Polymerisation Methods In General (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB1995/000287 WO1996033701A1 (en) | 1995-04-24 | 1995-04-24 | Inhibiting photodecomposition of 3-substituted-2-oxindoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9602024A true BR9602024A (pt) | 1998-10-06 |
Family
ID=36997502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9602024A BR9602024A (pt) | 1995-04-24 | 1996-04-24 | Método para a inibição da fotodecomposição de um composto comprimido e cápsula compreendendo um ingrediente farmaceuticamente ativo |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0827399A1 (sv) |
| JP (1) | JPH10506635A (sv) |
| KR (1) | KR100189585B1 (sv) |
| CN (1) | CN1053667C (sv) |
| AP (1) | AP607A (sv) |
| AR (1) | AR002728A1 (sv) |
| AU (1) | AU692378B2 (sv) |
| BG (1) | BG100531A (sv) |
| BR (1) | BR9602024A (sv) |
| CO (1) | CO4700418A1 (sv) |
| FI (1) | FI973988A (sv) |
| HR (1) | HRP960194A2 (sv) |
| HU (1) | HU216544B (sv) |
| IL (1) | IL117969A0 (sv) |
| IS (1) | IS4339A (sv) |
| MA (1) | MA23848A1 (sv) |
| NO (1) | NO961622L (sv) |
| NZ (1) | NZ286432A (sv) |
| OA (1) | OA10286A (sv) |
| PE (1) | PE34397A1 (sv) |
| RO (1) | RO113305B1 (sv) |
| RU (1) | RU2109510C1 (sv) |
| SG (1) | SG64924A1 (sv) |
| SI (1) | SI9600133A (sv) |
| SK (1) | SK51296A3 (sv) |
| TR (1) | TR199600300A2 (sv) |
| UA (1) | UA42739C2 (sv) |
| WO (1) | WO1996033701A1 (sv) |
| YU (1) | YU25096A (sv) |
| ZA (1) | ZA963210B (sv) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019132959A1 (en) | 2017-12-29 | 2019-07-04 | Kraft Foods Group Brands Llc | Improved oxidative stability of oil-in-water emulsions using natural stabilizers |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUT59592A (en) * | 1990-07-20 | 1992-06-29 | Egyt Gyogyszervegyeszeti Gyar | Process for the preparation of solid medical products |
| TW438798B (en) * | 1992-10-07 | 2001-06-07 | Pfizer | 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions |
-
1995
- 1995-04-24 SK SK512-96A patent/SK51296A3/sk unknown
- 1995-04-24 RU RU96108120A patent/RU2109510C1/ru active
- 1995-04-24 UA UA96041574A patent/UA42739C2/uk unknown
- 1995-04-24 EP EP95914494A patent/EP0827399A1/en not_active Ceased
- 1995-04-24 WO PCT/IB1995/000287 patent/WO1996033701A1/en not_active Application Discontinuation
- 1995-04-24 JP JP8532298A patent/JPH10506635A/ja active Pending
-
1996
- 1996-03-07 AP APAP/P/1996/000787A patent/AP607A/en active
- 1996-03-28 AR ARP960101956A patent/AR002728A1/es unknown
- 1996-04-10 TR TR96/00300A patent/TR199600300A2/xx unknown
- 1996-04-18 IL IL11796996A patent/IL117969A0/xx unknown
- 1996-04-19 IS IS4339A patent/IS4339A/is unknown
- 1996-04-19 SG SG1996009306A patent/SG64924A1/en unknown
- 1996-04-22 RO RO96-00843A patent/RO113305B1/ro unknown
- 1996-04-22 CO CO96019210A patent/CO4700418A1/es unknown
- 1996-04-22 CN CN96105084A patent/CN1053667C/zh not_active Expired - Fee Related
- 1996-04-22 PE PE1996000275A patent/PE34397A1/es not_active Application Discontinuation
- 1996-04-23 BG BG100531A patent/BG100531A/xx unknown
- 1996-04-23 NZ NZ286432A patent/NZ286432A/en unknown
- 1996-04-23 HU HU9601057A patent/HU216544B/hu not_active IP Right Cessation
- 1996-04-23 MA MA24209A patent/MA23848A1/fr unknown
- 1996-04-23 YU YU25096A patent/YU25096A/sh unknown
- 1996-04-23 ZA ZA9603210A patent/ZA963210B/xx unknown
- 1996-04-23 HR HRPCT/IB95/00287A patent/HRP960194A2/hr not_active Application Discontinuation
- 1996-04-23 AU AU50851/96A patent/AU692378B2/en not_active Ceased
- 1996-04-23 KR KR1019960012356A patent/KR100189585B1/ko not_active IP Right Cessation
- 1996-04-23 NO NO961622A patent/NO961622L/no unknown
- 1996-04-24 BR BR9602024A patent/BR9602024A/pt active Search and Examination
- 1996-04-24 OA OA60821A patent/OA10286A/en unknown
- 1996-04-24 SI SI9600133A patent/SI9600133A/sl not_active IP Right Cessation
-
1997
- 1997-10-17 FI FI973988A patent/FI973988A/sv unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR970006279A (ko) | 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물 | |
| CA2194167A1 (en) | Hair-growing agent | |
| IL117728A (en) | Pharmaceutical compositions for transdermal administration comprising an active principle a promotor and a solvent | |
| EE03925B1 (et) | Farmakoloogiliselt aktiivse aine valmistamise meetod | |
| HUP0004383A3 (en) | Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient | |
| IL116673A0 (en) | A pharmaceutical composition containing a benzimidazole derivative and processes for the preparation thereof | |
| AU5538098A (en) | A slow releasing physiologically active pharmaceutical and method of preparation thereof | |
| BR9600821A (pt) | Composto formulação farmacêutica e processo para a preparação de um composto | |
| ZA968767B (en) | Pharmaceutically active compounds | |
| AU7208494A (en) | Controlled release of pharmaceutically active substances from coacervate microcapsules | |
| BR9607095A (pt) | Composto composição farmacêutica e processos para fabricar e para administrar um composto | |
| ZA988718B (en) | Drug formulation having controlled release of active compound | |
| HUT75029A (en) | Systems for controlled release of pilocarpine, and semipermeable capsule containing the active ingredient | |
| ZA9610714B (en) | Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet | |
| GB9526511D0 (en) | Pharmaceutically active compounds | |
| ZA986320B (en) | A method for the preparation of tertiary amines a compound useful therefor and alpha-2-receptor active tetrahyd-roisoquinoline derivatives | |
| BR9602024A (pt) | Método para a inibição da fotodecomposição de um composto comprimido e cápsula compreendendo um ingrediente farmaceuticamente ativo | |
| BR9606066A (pt) | Composto e formulação farmacêutica | |
| KR970000225A (ko) | 시네프린을 유효성분으로 함유하는 우울증 치료제 | |
| ZA9810846B (en) | An active hedgehog-protein-mutant a process for its preparation and its use for pharmaceutical purposes | |
| AU6016496A (en) | Antianginal drug comprising nitroxy derivative as active ingredient | |
| IL112265A0 (en) | Hydrazone compound and insecticide containing said compound as active ingredient | |
| ZA95349B (en) | Hydrazone compound and insecticide containing said compound as active ingredient | |
| AU3027499A (en) | Method for developing a pharmaceutical active ingredient | |
| GB9513775D0 (en) | Pharmaceutically active compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB34 | Technical and formal requirements: requirement - article 34 of industrial property law | ||
| B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |